Respiratory syncytial virus: a new Italian study on prevention in newborns
Respiratory syncytial virus (RSV) is currently the leading cause of hospital admission for infants during their first year of life. This infection affects the respiratory tract and can cause severe forms of bronchiolitis, putting a strain on the Italian healthcare system and families.
Recently, Sapienza University of Rome published the largest analysis ever conducted in Italy on the efficacy of the new prophylaxis against this virus. The study aims to evaluate how new prevention strategies can significantly reduce the number of hospitalizations among newborns.
The research results offer essential data to better understand the impact of available preventive treatments. Thanks to this analysis, doctors and health authorities can plan more targeted interventions to protect the most vulnerable individuals during the winter months, the period when the virus circulates most widely.
Protecting newborns against RSV remains a priority for public health in Italy. The adoption of new prevention measures, supported by solid scientific data, represents an important step forward in ensuring the health of the youngest and reducing the workload on the country's pediatric hospitals.